These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

980 related items for PubMed ID: 12897775

  • 1. Genetic regulation of osteoclast development and function.
    Teitelbaum SL, Ross FP.
    Nat Rev Genet; 2003 Aug; 4(8):638-49. PubMed ID: 12897775
    [Abstract] [Full Text] [Related]

  • 2. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

  • 3. Osteoclast differentiation and activation.
    Boyle WJ, Simonet WS, Lacey DL.
    Nature; 2003 May 15; 423(6937):337-42. PubMed ID: 12748652
    [Abstract] [Full Text] [Related]

  • 4. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
    Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D.
    Cytokine Growth Factor Rev; 2004 Dec 15; 15(6):457-75. PubMed ID: 15561602
    [Abstract] [Full Text] [Related]

  • 5. RANKL-RANK signaling in osteoclastogenesis and bone disease.
    Wada T, Nakashima T, Hiroshi N, Penninger JM.
    Trends Mol Med; 2006 Jan 15; 12(1):17-25. PubMed ID: 16356770
    [Abstract] [Full Text] [Related]

  • 6. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.
    J Cell Physiol; 2004 Oct 15; 201(1):17-25. PubMed ID: 15281085
    [Abstract] [Full Text] [Related]

  • 7. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH, Lee CK, Lee YI, Paik SG, Lee HJ.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):437-46. PubMed ID: 16083856
    [Abstract] [Full Text] [Related]

  • 8. Regulation of osteoclast activity in peri-implant tissues.
    Haynes DR, Crotti TN, Zreiqat H.
    Biomaterials; 2004 Sep 23; 25(20):4877-85. PubMed ID: 15109848
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.
    Collin-Osdoby P.
    Circ Res; 2004 Nov 26; 95(11):1046-57. PubMed ID: 15564564
    [Abstract] [Full Text] [Related]

  • 13. RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons.
    Boissy P, Destaing O, Jurdic P.
    Biochem Biophys Res Commun; 2001 Oct 26; 288(2):340-6. PubMed ID: 11606048
    [Abstract] [Full Text] [Related]

  • 14. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 26; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.
    Blair JM, Zhou H, Seibel MJ, Dunstan CR.
    Nat Clin Pract Oncol; 2006 Jan 26; 3(1):41-9. PubMed ID: 16407878
    [Abstract] [Full Text] [Related]

  • 16. Interactions between immune and bone cells: new insights with many remaining questions.
    Lorenzo J.
    J Clin Invest; 2000 Sep 26; 106(6):749-52. PubMed ID: 10995785
    [No Abstract] [Full Text] [Related]

  • 17. Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease.
    Sattler AM, Schoppet M, Schaefer JR, Hofbauer LC.
    Calcif Tissue Int; 2004 Jan 26; 74(1):103-6. PubMed ID: 14523602
    [Abstract] [Full Text] [Related]

  • 18. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE, Wordsworth PB, Edwards JR, Ferguson DJ, Athanasou NA.
    Hum Pathol; 2006 Sep 26; 37(9):1176-85. PubMed ID: 16938523
    [Abstract] [Full Text] [Related]

  • 19. [[From metastatic osteolysis a painful message: beginning to understand with osteoprotegerin?].
    Bénard J.
    Bull Cancer; 2000 Sep 26; 87(9):623-4. PubMed ID: 11184451
    [No Abstract] [Full Text] [Related]

  • 20. Signal transduction pathways regulating osteoclast differentiation and function.
    Tanaka S, Nakamura I, Inoue J, Oda H, Nakamura K.
    J Bone Miner Metab; 2003 Sep 26; 21(3):123-33. PubMed ID: 12720046
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.